Cite
HARVARD Citation
Platzbecker, U. et al. (n.d.). A Phase 3 Randomized Placebo (PBO)-Controlled Double-Blind Trial of Darbepoetin Alfa in Low or Intermediate-1 (INT-1) Risk Myelodysplastic Syndromes (MDS). Leukemia research. pp. S29-S30. [Online].